about
Anticancer activity of VDR-coregulator inhibitor PS121912.Inhibitors for the Vitamin D Receptor-Coregulator Interaction.Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABAA) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic EfficacyParallel Chemistry Approach to Identify Novel Nuclear Receptor Ligands Based on the GW0742 Scaffold.Novel VDR antagonists based on the GW0742 scaffold.Development of posaconazole-based analogues as hedgehog signaling pathway inhibitorsProbing the Ligand-Binding Pocket of BTN3A1Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors
P50
Q34253023-53576917-F49C-4FF8-894B-85EE014856F8Q35909214-5D3B515A-8005-4C8A-A71B-58CB6FFF449AQ40819756-87C82D47-7E84-4ED6-A960-8833595FBC36Q47927975-82A80D28-C719-4B51-80F3-4B3137D71B0DQ49486984-B4E4411A-D245-40A7-859A-6E5665FDB70AQ90359100-94506470-5036-4214-B746-28B0A51F52E0Q91579367-25DB18AD-CD4A-4073-8B8E-2CF05192A3A2Q92525503-21679649-E92C-483B-8FA0-6B6977CAE255
P50
description
researcher (ORCID 0000-0002-1319-5025)
@en
name
Kelly A Teske
@en
type
label
Kelly A Teske
@en
prefLabel
Kelly A Teske
@en
P31
P496
0000-0002-1319-5025